Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › AZ › Cottonwood › NPI 1346291648
Hospital

Verde Valley Medical Center

Verde Valley Medical Center was paid $26.43M by Medicaid between Jan 2018 and Dec 2024, across 246 billing codes. Its largest line is 99284, emergency room visit (serious) — 18% of everything it billed.

33Billing provider infoVERDE VALLEY MEDICAL CENTER
COTTONWOOD, AZ 86326
33aNPI1346291648assigned 05/12/2006
28Total paid$26.43M
24GClaims620,081
24DCodes billed246
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers

Next to other General Acute Care Hospital providers in Arizona

Rank by total paid#21 of 78
Median peer was paid$12.21M
This provider vs. median2.2×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

$0$200K$400K$600K2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
2018113,404$4.55M
201995,695$4.08M
202085,665$3.48M
202179,331$3.42M
202281,430$3.79M
202392,928$3.84M
2024incomplete71,628$3.27M
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
99284 Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity 18% 20,889 18,432 $4.79M
99283 Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity 16% 20,007 18,318 $4.25M
74177 Computed tomography, abdomen and pelvis; with contrast material 14% 5,536 5,154 $3.61M
99285 Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life 10% 8,687 7,730 $2.66M
G0378 Hospital observation service, per hour 5.1% 7,876 5,336 $1.36M
97110 Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion 4.5% 44,168 13,545 $1.20M
70450 Computed tomography, head or brain; without contrast material 2.4% 4,972 4,483 $636K
74176 Computed tomography, abdomen and pelvis; without contrast material 2.1% 1,417 1,315 $546K
0202U Oncology (prostate), multianalyte, gene expression profiling 2.1% 2,645 2,541 $543K
71275 Computed tomographic angiography, chest, with contrast material 1.8% 1,421 1,326 $477K
72125 Computed tomography, cervical spine; without contrast material 1.7% 1,443 1,330 $448K
99282 Emergency department visit for the evaluation and management, low to moderate severity 1.5% 4,272 4,051 $388K
234 more codes
93306 Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete 1.2% 1,519 $313K
97140 Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) <1% 23,189 $261K
71046 Radiologic examination, chest; 2 views <1% 8,323 $238K
87633 Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets <1% 823 $226K
43239 Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple <1% 336 $214K
72100 <1% 2,856 $201K
76830 Ultrasound, transvaginal <1% 1,528 $183K
92507 Treatment of speech, language, voice, communication, and/or auditory processing disorder <1% 3,652 $174K
45380 Colonoscopy, flexible; with biopsy, single or multiple <1% 337 $153K
73564 <1% 1,888 $137K
97530 Therapeutic activities, direct patient contact, each 15 minutes <1% 7,709 $133K
88305 Level IV - Surgical pathology, gross and microscopic examination <1% 2,412 $127K
72148 Magnetic resonance imaging, lumbar spine; without contrast material <1% 815 $125K
70551 Magnetic resonance imaging, brain; without contrast material <1% 469 $123K
73110 <1% 2,488 $115K
76700 Ultrasound, abdominal, real time with image documentation; complete <1% 1,369 $112K
72040 <1% 1,437 $110K
73610 <1% 2,491 $105K
77067 Screening mammography, bilateral, including computer-aided detection <1% 2,947 $102K
73030 <1% 3,049 $101K
80053 Comprehensive metabolic panel <1% 28,264 $101K
59025 Fetal non-stress test <1% 1,186 $99K
97112 Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination <1% 6,422 $95K
70553 Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences <1% 246 $94K
73562 <1% 3,007 $88K
73630 <1% 2,939 $87K
73130 <1% 2,575 $80K
97161 <1% 4,206 $78K
94726 <1% 205 $77K
71260 Computed tomography, thorax, diagnostic; with contrast material <1% 480 $74K
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r <1% 914 $73K
73721 Magnetic resonance imaging, any joint of lower extremity; without contrast material <1% 441 $72K
76705 Ultrasound, abdominal, real time with image documentation; limited <1% 1,997 $65K
76536 <1% 762 $60K
73502 <1% 1,748 $59K
97597 <1% 834 $58K
74018 <1% 1,538 $55K
78452 Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress <1% 67 $52K
77080 <1% 979 $52K
71250 <1% 519 $48K
93005 Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report <1% 13,631 $44K
93010 Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only <1% 7,495 $38K
97535 Self-care/home management training, each 15 minutes <1% 3,573 $37K
76642 <1% 531 $36K
72072 <1% 516 $34K
93971 <1% 1,108 $34K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe <1% 1,685 $34K
76770 <1% 411 $28K
97162 <1% 1,698 $26K
95811 <1% 39 $25K
76641 <1% 177 $23K
96365 Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour <1% 5,362 $22K
87637 Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV <1% 2,953 $21K
73221 <1% 127 $21K
72141 <1% 132 $21K
J7050 Infusion, normal saline solution, 250 cc <1% 4,968 $18K
96361 Intravenous infusion, hydration; each additional hour <1% 9,559 $16K
71045 Radiologic examination, chest; single view <1% 8,109 $16K
97165 <1% 658 $15K
73080 <1% 418 $13K
70486 <1% 199 $13K
93017 <1% 252 $12K
84443 Thyroid stimulating hormone (TSH) <1% 3,151 $11K
12001 <1% 93 $11K
87641 <1% 614 $11K
96374 Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance <1% 13,520 $8K
76856 Ultrasound, pelvic (nonobstetric), real time with image documentation; complete <1% 1,770 $7K
J0696 Injection, ceftriaxone sodium, per 250 mg <1% 2,498 $7K
76937 <1% 59 $7K
77336 <1% 47 $6K
99214 Doctor's office visit, returning patient (more involved) <1% 444 $6K
73140 <1% 215 $6K
96360 Intravenous infusion, hydration; initial, 31 minutes to 1 hour <1% 3,162 $6K
99460 <1% 82 $5K
87186 <1% 1,450 $5K
73090 <1% 206 $5K
97116 <1% 1,328 $5K
87502 Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets <1% 236 $5K
97750 <1% 349 $5K
99215 Doctor's office visit, returning patient (complex) <1% 177 $5K
99213 Doctor's office visit, returning patient (routine) <1% 330 $4K
80048 Basic metabolic panel (calcium, ionized) <1% 5,203 $4K
97166 <1% 70 $4K
99211 Office or other outpatient visit for the evaluation and management of an established patient, minimal severity <1% 100 $4K
99281 Emergency department visit for the evaluation and management, self-limited or minor <1% 57 $4K
87798 Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism <1% 622 $4K
97032 <1% 1,555 $4K
J3490 Unclassified drugs <1% 3,701 $4K
87040 <1% 1,974 $4K
85025 Blood count; complete (CBC), automated, and automated differential WBC count <1% 33,053 $4K
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed <1% 1,587 $4K
G0379 Direct admission of patient for hospital observation care <1% 1,636 $4K
72110 <1% 42 $4K
96375 Therapeutic injection; each additional sequential IV push <1% 9,667 $4K
96366 Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour <1% 944 $3K
99238 Hospital discharge day management, 30 minutes or less <1% 51 $3K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay <1% 5,669 $3K
94060 <1% 187 $3K
93880 <1% 41 $3K
90715 <1% 740 $3K
73590 <1% 110 $3K
70496 <1% 14 $2K
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction <1% 2,333 $2K
70498 <1% 42 $2K
87631 <1% 688 $2K
96413 Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance <1% 216 $2K
72131 <1% 26 $2K
J2270 Injection, morphine sulfate, up to 10 mg <1% 4,116 $2K
87077 <1% 1,450 $2K
J7030 Infusion, normal saline solution , 1000 cc <1% 5,754 $2K
76801 <1% 66 $2K
83880 <1% 1,997 $2K
G0463 Hospital outpatient clinic visit for assessment and management of a patient <1% 151 $1K
87088 <1% 5,249 $1K
36415 Collection of venous blood by venipuncture <1% 37,532 $1K
J1815 Injection, insulin, per 5 units <1% 18 $1K
73700 <1% 14 $1K
80329 <1% 2,117 $1K
95812 <1% 14 $1K
J2930 Injection, methylprednisolone sodium succinate, up to 125 mg <1% 276 $1K
97035 <1% 422 $1K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular <1% 4,163 $1K
74019 <1% 39 $1K
84484 <1% 7,727 $1K
77066 Tomosynthesis, mammo <1% 305 $1K
83690 <1% 8,091 $838.30
71271 <1% 12 $824.29
J2060 Injection, lorazepam, 2 mg <1% 1,774 $774.51
83605 <1% 6,063 $767.05
81025 <1% 4,943 $746.77
J1170 Injection, hydromorphone, up to 4 mg <1% 1,164 $732.28
85610 <1% 7,201 $725.89
86141 <1% 209 $598.97
86140 <1% 464 $597.23
84703 <1% 2,576 $554.60
81001 <1% 10,620 $537.54
87651 Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe <1% 416 $527.67
83735 <1% 5,137 $519.76
94729 <1% 230 $475.20
83036 Hemoglobin; glycosylated (A1C) <1% 504 $473.42
J1885 Injection, ketorolac tromethamine, per 15 mg <1% 6,238 $434.67
85379 <1% 1,640 $433.94
77065 Tomosynthesis, mammo <1% 55 $421.92
J2405 Injection, ondansetron hydrochloride, per 1 mg <1% 7,032 $387.17
85730 <1% 2,109 $382.60
87086 Culture, bacterial; quantitative colony count, urine <1% 2,676 $365.45
84702 <1% 551 $324.99
J7120 Ringers lactate infusion, up to 1000 cc <1% 28 $305.00
82803 <1% 570 $262.36
87070 <1% 254 $244.82
74022 <1% 12 $242.86
96376 <1% 2,689 $226.81
80061 Lipid panel <1% 300 $216.01
A9270 Non-covered item or service <1% 2,916 $210.23
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml <1% 8,229 $204.67
88342 <1% 98 $187.21
87426 Infectious agent antigen detection, SARS-CoV-2 (COVID-19) <1% 244 $154.89
82140 <1% 31 $151.03
86900 <1% 1,035 $139.09
80320 <1% 3,997 $137.69
81003 <1% 5,186 $137.68
97803 <1% 13 $109.65
G0108 Diabetes outpatient self-management training services, individual, per 30 minutes <1% 16 $92.27
82962 <1% 3,984 $89.39
J1100 Injection, dexamethasone sodium phosphate, 1 mg <1% 1,395 $87.98
90471 Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine <1% 891 $81.27
J3010 Injection, fentanyl citrate, 0.1 mg <1% 2,545 $80.48
86901 <1% 763 $70.75
82550 <1% 1,216 $65.31
82150 <1% 237 $58.18
J1200 Injection, diphenhydramine hcl, up to 50 mg <1% 1,798 $56.82
84100 <1% 1,747 $56.17
J3480 Injection, potassium chloride, per 2 meq <1% 94 $54.09
86850 <1% 462 $53.23
96367 <1% 43 $49.42
82776 <1% 12 $47.80
97016 <1% 5,254 $46.56
87581 <1% 586 $45.75
87486 <1% 586 $45.75
J2765 Injection, metoclopramide hcl, up to 10 mg <1% 1,079 $45.33
U0005 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 <1% 912 $25.00
84145 <1% 148 $17.77
J1644 Injection, heparin sodium, per 1000 units <1% 296 $12.82
J1630 Injection, haloperidol, up to 5 mg <1% 68 $6.31
S0164 Injection, pantoprazole sodium, 40 mg <1% 92 $5.00
87205 <1% 262 $4.01
J7040 Infusion, normal saline solution, sterile (500 ml = 1 unit) <1% 351 $2.48
85652 <1% 472 $1.73
S0028 Injection, famotidine, 20 mg <1% 305 $0.95
77063 Screening digital breast tomosynthesis, bilateral <1% 2,709 $0.36
G8985 Carrying, moving and handling objects, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting <1% 150 $0.02
94760 0% 1,448 $0.00
A9579 Injection, gadolinium-based magnetic resonance contrast agent, not otherwise specified (nos), per ml 0% 877 $0.00
G8980 Mobility: walking & moving around functional limitation, discharge status, at discharge from therapy or to end reporting 0% 104 $0.00
G8987 Self care functional limitation, current status, at therapy episode outset and at reporting intervals 0% 28 $0.00
J2360 Injection, orphenadrine citrate, up to 60 mg 0% 146 $0.00
C9399 Unclassified drugs or biologicals 0% 95 $0.00
J1790 Injection, droperidol, up to 5 mg 0% 80 $0.00
J7512 Prednisone, immediate release or delayed release, oral, 1 mg 0% 147 $0.00
A9500 Technetium tc-99m sestamibi, diagnostic, per study dose 0% 83 $0.00
G8988 Self care functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting 0% 61 $0.00
88738 0% 71 $0.00
97014 0% 30 $0.00
J2003 Injection, lidocaine hydrochloride, 1 mg 0% 34 $0.00
J2250 Injection, midazolam hydrochloride, per 1 mg 0% 65 $0.00
G8982 Changing & maintaining body position functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting 0% 42 $0.00
85027 0% 50 $0.00
J2470 Injection, pantoprazole sodium, 40 mg 0% 57 $0.00
G8981 Changing & maintaining body position functional limitation, current status, at therapy episode outset and at reporting intervals 0% 17 $0.00
76817 Ultrasound, pregnant uterus, real time with image documentation, transvaginal 0% 15 $0.00
J2785 Injection, regadenoson, 0.1 mg 0% 14 $0.00
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe 0% 20 $0.00
J3535 Drug administered through a metered dose inhaler 0% 13 $0.00
88304 0% 12 $0.00
G8991 Other physical or occupational therapy primary functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting 0% 15 $0.00
82270 0% 27 $0.00
G1004 Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program 0% 3,200 $0.00
J0780 Injection, prochlorperazine, up to 10 mg 0% 203 $0.00
G0279 Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) 0% 84 $0.00
84439 0% 64 $0.00
J3475 Injection, magnesium sulfate, per 500 mg 0% 360 $0.00
G8979 Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting 0% 618 $0.00
G8978 Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals 0% 493 $0.00
94799 0% 36 $0.00
S4991 Nicotine patches, non-legend 0% 15 $0.00
77061 0% 12 $0.00
77062 0% 38 $0.00
J2272 Injection, morphine sulfate (fresenius kabi), not therapeutically equivalent to j2270, up to 10 mg 0% 16 $0.00
C9113 Injection, pantoprazole sodium, per vial 0% 47 $0.00
29125 0% 14 $0.00
G8984 Carrying, moving & handling objects functional limitation, current status, at therapy episode outset and at reporting intervals 0% 63 $0.00
A4216 Sterile water, saline and/or dextrose, diluent/flush, 10 ml 0% 40 $0.00
J1171 Injection, hydromorphone, 0.1 mg 0% 35 $0.00
76376 0% 43 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialCOFIELD, ROBERT (CHIEF OPERATING OFFICER)
Same official

Other billing entities under COFIELD, ROBERT

Full network →

Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.